LiDCO Group Plc

Offer details

Expected size of offer (M):	-
Expected first date of trading:	05/07/2001
Market:	AIM
Location of address at which admission document will be available:	Teather & Greenwood Beaufort House 15 St.Botolph St London EC3A 7QR
Date at which admission document will be available:	-

Advisors

Sponsor:	-
Nominated Advisor (AIM Companies):	Teather and Greenwood
Nominated Broker (AIM Companies):	Teather and Greenwood
Financial PR Advisors:	-

Company details

Name	Role
Theodore William Alexander	Chairman
Dr Terence Kevin O'Brien	Chief Executive Officer
Dr David Marston Band	Scientific Director
Richard John Mill	Finance Director Finance Director
John Gerard Barry	Sales and Marketing Director
Pascal Norman Levensohn	Non-executive Director
Albert Edward Bernard Wiegman	Non-executive Director

Facts and Figures

Fiscal year end:	- -
Incorporated in:	England & Wales
Website URL:	http://

Description of business:
Research, development, manufacture and sale of cardiovascular monitoring medical devices primarily for critical care and cardiovascular risk hospital patients who require real-time cardiovascular monitoring while undergoing major surgery, intensive care or cardiology procedures.

Person(s) interested:
Robert Linton; Jiri Kratochvil; King's College London; and Merlin Biosciences Fund LP All to be confirmed